SCHEMBL16016989

SCHEMBL16016989

CO[C@@H]1Cc2c(OCc3ccccc3)cc(C)cc2O[C@@H]1c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ PDE4C Q08493 1/20 0.42
▸ PDE4D Q08499 1/20 0.42
▸ STING1 Q86WV6 1/20 0.42
▸ APP P05067 2/20 0.39
▸ MAPT P10636 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ PRMT5 O14744 1/20 0.38
▸ CETP P11597 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ F10 P00742 3/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB2 P47870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17358245 0.92 STING1 (0.42) PDE4APDE4BPDE4CPDE4DSTING1
SCHEMBL17358236 0.92 STING1 (0.42) PDE4APDE4BPDE4CPDE4DSTING1
SCHEMBL17358246 0.92 STING1 (0.42) PDE4APDE4BPDE4CPDE4DSTING1
SCHEMBL16016991 0.87 ALDH1A1 (0.55) PDE4APDE4BPDE4CPDE4DSTING1
SCHEMBL16016915 0.86 CYP3A4 (0.44) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL15450266 0.86 CYP3A4 (0.44) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL15450257 0.86 CYP3A4 (0.44) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL15450263 0.86 CYP3A4 (0.44) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL15450265 0.83 STING1 (0.43) PDE4APDE4BPDE4CPDE4DSTING1
SCHEMBL15450261 0.83 STING1 (0.43) PDE4APDE4BPDE4CPDE4DSTING1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9187448-B2 Flavonoid compounds CARDERO THERAPEUTICS, INC. (US) 2015-11-17 — — US disclosed
US-20140256741-A1 FLAVONOID COMPOUNDS CARDERO THERAPEUTICS, INC. (US) 2014-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256741-A1 FLAVONOID COMPOUNDS FIS1, TFAM, MFN2 PDE4A 1368/4885PDE4B 1210/4885PDE4C 1408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback